The life sciences practice at Hogan Lovells International LLP has expertise spanning pharmaceuticals, medical devices, and healthcare regulatory issues, advising leading pharmaceutical clients on contentious and non-contentious matters. Fabien Roy acts as head of the practice, with particular knowledge of pharma, medical devices, and in vitro diagnostic devices. Cláudia Mendes Pinto is key to the team, frequently working on EU and global projects, focusing on advanced therapy medicinal products. Helene Boland is also noted.
L’éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • Adverum Biotechnologies
  • Balt USA, LLC
  • Celgene Corporation
  • Dexcom, Inc.
  • Establishment Labs
  • Synapse Biomedical, Inc.

Points forts

  • Advising Adverum, a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, on setting up a GDPR-compliant framework for their upcoming clinical trials in the EU and UK and on future clinical activities in the EU/UK.
  • Advising Celgene on an ongoing basis with supply chain, manufacturing, and clinical trials regulatory aspects throughout Europe.
  • Advising clients on the transition of their devices from the Medical Devices Directive to the Medical Devices Regulation.

Avocats

Les grands avocats de demain

Jeunes associés disposant d’une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.

Meilleurs collaborateurs

Jeunes avocats collaborateurs ou counsels qui se distinguent régulièrement par leur présence dans des dossiers importants du marché, et qui sont identifiés par le marché comme de jeunes talents à suivre.

Cláudia Mendes Pinto

Responsable de la pratique

Fabien Roy

Autres avocats clés

Claudia Mendes Pinto; Helene Boland